Lexirin: LXR will start this month a Phase I trial of Lexirin in AIDS patients with severe diarrhea.

LXR Biotechnology Inc. (LXR), Richmond, Calif. Product: Lexirin, small molecule apoptosis modulator Indication: Severe diarrhea in AIDS Status: LXR will start this month a Phase I trial of Lexirin in ...